Home › Funds › Citigroup Inc › CGEM
Citigroup Inc position in CGEM
CULLINAN THERAPEUTICS INC · Health Care
Latest position (Q2 2026)124.41K sh
Reported value held$2.27M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 3.17K | $72.00K | New |
| Q4 2021 | 60.68K | $936.00K | Add |
| Q1 2022 | 10.76K | $113.00K | Reduce |
| Q2 2022 | 3.12K | $40.00K | Reduce |
| Q3 2022 | 1.33K | $17.00K | Reduce |
| Q4 2022 | 1.13K | $11.88K | Reduce |
| Q1 2023 | 17.24K | $176.35K | Add |
| Q2 2023 | 8.23K | $88.51K | Reduce |
| Q3 2023 | 23.53K | $212.98K | Add |
| Q4 2023 | 10.57K | $107.71K | Reduce |
| Q1 2024 | 85.57K | $1.46M | Add |
| Q2 2024 | 22.11K | $385.55K | Reduce |
| Q3 2024 | 38.39K | $642.62K | Add |
| Q4 2024 | 80.67K | $982.60K | Add |
| Q1 2025 | 81.00K | $613.17K | Hold |
| Q2 2025 | 26.49K | $199.48K | Reduce |
| Q3 2025 | 107.17K | $635.55K | Add |
| Q4 2025 | 240.46K | $2.49M | Add |
| Q1 2026 | 144.11K | $2.05M | Reduce |
| Q2 2026 | 124.41K | $2.27M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CGEM
- BlackRock Inc 5.23M sh · $95.29M · Q2 2026
- Vanguard Group 3.30M sh · $34.14M · Q4 2025
- Geode Capital Management 1.55M sh · $28.18M · Q2 2026
- Goldman Sachs Group 1.00M sh · $18.24M · Q2 2026
- Morgan Stanley 629.03K sh · $11.45M · Q2 2026
- AQR Capital Management 581.34K sh · $10.59M · Q2 2026
- Northern Trust Corp 571.08K sh · $10.40M · Q2 2026
- Bank of America Corp 510.32K sh · $9.29M · Q2 2026
- Charles Schwab Investment Management 464.03K sh · $8.45M · Q2 2026
- Deutsche Bank AG 382.84K sh · $6.97M · Q2 2026
- Millennium Management 366.23K sh · $6.67M · Q2 2026
- Renaissance Technologies 326.81K sh · $5.95M · Q2 2026